Ghanavati E, Salehinejad M, Beaupain M, Melo L, Frese A, Kuo M
Hum Brain Mapp. 2025; 46(3):e70162.
PMID: 39945316
PMC: 11822652.
DOI: 10.1002/hbm.70162.
Lachance K, Pelland-Goulet P, Gosselin N
Front Psychol. 2025; 15:1508181.
PMID: 39911190
PMC: 11797425.
DOI: 10.3389/fpsyg.2024.1508181.
Petersson M, Uvnas-Moberg K
Biomedicines. 2024; 12(11).
PMID: 39595007
PMC: 11591571.
DOI: 10.3390/biomedicines12112440.
Gulec A, Turkoglu S, Kocabas R
J Neural Transm (Vienna). 2024; 132(1):157-168.
PMID: 39249516
DOI: 10.1007/s00702-024-02831-w.
Hao Y, Li B, Huang D, Wu S, Wang T, Fu L
Int J Mol Sci. 2024; 25(15).
PMID: 39125808
PMC: 11312053.
DOI: 10.3390/ijms25158239.
Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.
Ijomone O, Oria R, Ijomone O, Aschner M, Bornhorst J
Mol Neurobiol. 2024; 62(2):2420-2434.
PMID: 39110391
PMC: 11772124.
DOI: 10.1007/s12035-024-04418-8.
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review.
Wang W, Pan D, Liu Q, Chen X, Wang S
Nutrients. 2024; 16(8).
PMID: 38674921
PMC: 11055039.
DOI: 10.3390/nu16081232.
Neural mechanisms of dopamine function in learning and memory in .
McMillen A, Chew Y
Neuronal Signal. 2024; 8(1):NS20230057.
PMID: 38572143
PMC: 10987485.
DOI: 10.1042/NS20230057.
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia.
Alvarez-Herrera S, Rosel Vales M, Perez-Sanchez G, Becerril-Villanueva E, Flores-Medina Y, Maldonado-Garcia J
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399382
PMC: 10892557.
DOI: 10.3390/ph17020167.
A Facile Graphene Conductive Polymer Paper Based Biosensor for Dopamine, TNF-α, and IL-6 Detection.
Rahman M, Pal R, Islam N, Freeman R, Berthiaume F, Mazzeo A
Sensors (Basel). 2023; 23(19).
PMID: 37836943
PMC: 10575219.
DOI: 10.3390/s23198115.
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D
Cochrane Database Syst Rev. 2023; 10:CD011769.
PMID: 37811711
PMC: 10561353.
DOI: 10.1002/14651858.CD011769.pub2.
Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective.
van Ruitenbeek P, Franzen L, Mason N, Stiers P, Ramaekers J
Front Psychiatry. 2023; 14:1208120.
PMID: 37599874
PMC: 10435872.
DOI: 10.3389/fpsyt.2023.1208120.
Inflammation, Dopaminergic Brain and Bilirubin.
Jayanti S, Verde C, Tiribelli C, Gazzin S
Int J Mol Sci. 2023; 24(14).
PMID: 37511235
PMC: 10380707.
DOI: 10.3390/ijms241411478.
Altered neurovascular coupling in the children with attention-deficit/hyperactivity disorder: a comprehensive fMRI analysis.
Su S, Zhao J, Dai Y, Lin L, Zhou Q, Yan Z
Eur Child Adolesc Psychiatry. 2023; 33(4):1081-1091.
PMID: 37222790
DOI: 10.1007/s00787-023-02238-0.
Hyperfocus symptom and internet addiction in individuals with attention-deficit/hyperactivity disorder trait.
Ishii S, Takagi S, Kobayashi N, Jitoku D, Sugihara G, Takahashi H
Front Psychiatry. 2023; 14:1127777.
PMID: 37009127
PMC: 10061009.
DOI: 10.3389/fpsyt.2023.1127777.
The effects of propofol anaesthesia on molecular-enriched networks during resting-state and naturalistic listening.
Lawn T, Martins D, ODaly O, Williams S, Howard M, Dipasquale O
Neuroimage. 2023; 271:120018.
PMID: 36935083
PMC: 10410200.
DOI: 10.1016/j.neuroimage.2023.120018.
Analysis of neurotransmitters validates the importance of the dopaminergic system in autism spectrum disorder.
Saha S, Chatterjee M, Dutta N, Sinha S, Mukhopadhyay K
World J Pediatr. 2023; 19(8):770-781.
PMID: 36847977
DOI: 10.1007/s12519-023-00702-0.
Automatic and controlled attentional orienting toward emotional faces in patients with Parkinson's disease.
Righi S, Gronchi G, Ramat S, Gavazzi G, Cecchi F, Viggiano M
Cogn Affect Behav Neurosci. 2023; 23(2):371-382.
PMID: 36759426
PMC: 10050058.
DOI: 10.3758/s13415-023-01069-5.
Association between Exposure to Particulate Matter Air Pollution during Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder in Taiwan.
Fan H, Chen C, Tsai J, Chiang K, Tsai S, Huang C
Int J Environ Res Public Health. 2022; 19(23).
PMID: 36498210
PMC: 9740780.
DOI: 10.3390/ijerph192316138.
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD.
Sveinsdottir H, Christensen C, Borsteinsson H, Lavalou P, Parker M, Shkumatava A
Neuropsychopharmacology. 2022; 48(8):1155-1163.
PMID: 36400921
PMC: 10267219.
DOI: 10.1038/s41386-022-01505-z.